22-km distributed temperature sensor using Brillouin gain in an optical fiber

We describe an experimental distributed temperature sensor that uses the temperature dependence of the Brillouin frequency shift. When a 22.2-km sensing length is used, we have observed a temperature resolution of 1 degrees C and have obtained a spatial resolution of 10 m.

Principal optical constants measurement of uniaxial crystal CdSe in the wavelength region between 380 and 950 nm

The principal optical constants n(o), k(o), n(e), and k(e) of the hexagonal crystal CdSe are determined in the wavelength region between 380 and 950 nm at room temperature. The minimum reflectivities and the corresponding Brewster angles of parallel polarized light are measured for ordinary and extraordinary rays in the wavelength region between 380 and 728 nm. At longer wavelengths (k(o) < 10(-3)) Brewsterangle measurements and transmission measurements were applied. A plot of the absorption coefficients alpha(o) and alpha(e) versus wavelength indicates deviations from a direct band-gap parabolic absorption dependence.

[Study and preparation of Vi-PHA reagent and its application for detection of Salmonella typhi carriers]

Purified S. typhi Vi antigen is sensitized with equal volume of tannic acid treated formalational sheep erythrocytes (SRBC) at a final concentration of 1 microgram/ml. The Vi-passive hemagglutination assay (Vi-PHA) diagnostic reagent is developed to detect Vi antibodies to S. typhi for the detection of chronic carriers after typhoid fever and the screening S. typhi healthy carriers from food-handlers, which is characterized with high sensitivity, strong specificity and good stability. This Vi-PHA reagent is able to detect 1.16 micrograms/ml of Vi antibodies and doesn't make any cross reaction with healthy sera. For the sera of other diseases, the cross rate is only 0.84%. Using this reagent, 19 positive sera (6.93%) are detected from 274 convalescent sera from typhoid fever, 14 convalescents of which are stool-culture S. typhi positive, that persists a positive rate of 73.68%; 3 positive sera are detected from 106 foodhandlers, one of which is stool-culture S. typhi positive. Therefore, the reagent is simple, convenient, rapid and easy to be applicated in basic unit.

[Effect of second somatonorm treatment in idiopathic growth hormone deficiency dwarfism]

Nine previously treated idiopathic growth hormone deficiency children were treated again with recombinant hGH for one year. The dosage and route of administration were the same as those in the previous treatment. The height velocity increased from 1.5 +/- 1.0 cm/year (mean +/- SD) to 9.2 +/- 1.2 cm/year. Compared with the height velocity (10.7 +/- 0.5 cm/a) in the first year treatment, it decreased in the second year (P less than 0.05). The results also showed that the effect was better with a dosage of 0.7 IU/kg/wk divided into 7 s.c. doses than with 0.5 IU/kg/wk divided into 3 i.m. doses. Eight of the 9 cases had low serum T4 after treatment, but no symptoms of hypothyroidism were seen. Anti-hGH antibody was observed in 2 cases, though it did not affect the height velocity. No other side effects were noticed during treatment.